Analyst firms · Oppenheimer · CHWY
Oppenheimer CHWY price target and rating history
Chewy Inc. (CHWY) · Consumer Discretionary
Oppenheimer rates Chewy Inc. (CHWY) Perform with a $35 price target, as of its latest action on Sep 20, 2023. It has published 3 rating actions on CHWY since October 2022, including 0 upgrades and 1 downgrade. Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
- Current rating
- Perform
- Price target
- $35
- Median target, all firms
- $25
- Actions on CHWY
- 3
Oppenheimer price target on CHWY
Every Oppenheimer rating on CHWY
- Sep 20, 2023
- Aug 31, 2023
- Oct 7, 2022
How other firms rate CHWY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Hold | $22 | Nov 17, 2026 |
| Evercore ISI | In-line | $25 | Sep 10, 2026 |
| Rosenblatt | Neutral | $25 | Aug 20, 2026 |
| MoffettNathanson | Neutral | Jun 11, 2026 | |
| Raymond James | Outperform | $28 | Feb 19, 2026 |
Questions about Oppenheimer and CHWY
- What is Oppenheimer's price target for CHWY?
- Oppenheimer's latest stated price target for Chewy Inc. (CHWY) is $35, from its action on Aug 31, 2023.
- What is Oppenheimer's rating on CHWY?
- Oppenheimer rates CHWY Perform, a neutral rating, as of Sep 20, 2023.
- When did Oppenheimer last change its view on CHWY?
- On Sep 20, 2023, Oppenheimer downgrades to Perform from Outperform.
- How does Oppenheimer's CHWY target compare with other analysts?
- Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
More CHWY rating histories
- Evercore ISI3
- MoffettNathanson3
- Raymond James3
- Deutsche Bank3
- Mizuho4
- Jefferies4
- Argus Research4
- Wolfe Research4
- BNP Paribas Exane3
- Citigroup3
- Needham4
- Piper Sandler4
- Barclays4
- Goldman Sachs4
- Morgan Stanley4
- UBS3
- Robert W. Baird3
- Wedbush5
All Oppenheimer ratingsCHWY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.